In this study, we observed that tumor-inhibiting associated immune cells were significantly increased in low-risk patients, suggesting that UPS-related risk genes might facilitate reshaping the evolution of HCC through regulating immune cell infiltration. This evidence concerns the gene HMBS and hepatocellular carcinoma.